BioCentury | Oct 20, 2014
Clinical News

Sulfur hexafluoride lipid-type A microspheres regulatory update

...reactions. The product is marketed as SonoVue outside the U.S., including countries in the EU. Bracco Diagnostics Inc....
BioCentury | Aug 12, 2013
Company News

Bracco Diagnostics, Emergent BioSolutions deal

...Emergent completed its acquisition of the Healthcare Protective Products Division ( HPPD ) of Bracco's Bracco Diagnostics Inc....
...$26 million in cash up front, plus sales and development milestones (see BioCentury, May 13). Bracco Diagnostics Inc....
BioCentury | May 13, 2013
Company News

Bracco Diagnostics, Emergent BioSolutions deal

...Emergent will acquire the Healthcare Protective Products Division ( HPPD ) of Bracco's Bracco Diagnostics Inc. subsidiary for...
...$281.9 million in 2012 revenues, said HPPD revenues from 2010-12 averaged about $20 million annually. Bracco Diagnostics Inc....
BioCentury | Apr 15, 2013
Clinical News

Sonus regulatory update

...issued the injunction in April in response to an appeal by four companies - SNUS, Bracco Diagnostics Inc....
BioCentury | Jan 7, 2013
Company News

Advaxis management update

...O'Connor as SVP, chief legal and business development officer, formerly VP and general counsel at Bracco Diagnostics Inc. WIR...
BioCentury | Aug 6, 2012
Clinical News

MultiHance gadobenate dimeglumine regulatory update

...vascularity of the brain, spine and associated tissues. The product is also approved in Europe. Bracco Diagnostics Inc....
BioCentury | Feb 27, 2012
Clinical News

CardioGen-82 regulatory update

...radiation exposure during treatment. Bracco co-promotes CardioGen-82 with Lantheus Medical Imaging Inc. (North Billerica, Mass.). Bracco Diagnostics Inc....
BioCentury | Apr 7, 2011
Politics & Policy

FDA panel to discuss ultrasound contrast agents

...Co. (NYSE:GE); and an agent not approved in the U.S., sulfur hexafluoride microbubble injection from Bracco Diagnostics Inc....
BioCentury | Dec 14, 2009
Clinical News

Eovist gadoxetate disodium regulatory update

...from Bracco; as well as generics gadoteric acid and gadobutrol. Bayer AG (Xetra:BAY), Leverkusen, Germany Bracco Diagnostics Inc....
BioCentury | Dec 14, 2009
Clinical News

Eovist gadoxetate disodium regulatory update

...three products, but also discussed safety data for MultiHance gadobenate dimeglumine and ProHance gadoteridol from Bracco Diagnostics Inc....
...label to contraindicate its use in patients with renal impairment. Bayer AG (Xetra:BAY), Leverkusen, Germany Bracco Diagnostics Inc....
Items per page:
1 - 10 of 25
BioCentury | Oct 20, 2014
Clinical News

Sulfur hexafluoride lipid-type A microspheres regulatory update

...reactions. The product is marketed as SonoVue outside the U.S., including countries in the EU. Bracco Diagnostics Inc....
BioCentury | Aug 12, 2013
Company News

Bracco Diagnostics, Emergent BioSolutions deal

...Emergent completed its acquisition of the Healthcare Protective Products Division ( HPPD ) of Bracco's Bracco Diagnostics Inc....
...$26 million in cash up front, plus sales and development milestones (see BioCentury, May 13). Bracco Diagnostics Inc....
BioCentury | May 13, 2013
Company News

Bracco Diagnostics, Emergent BioSolutions deal

...Emergent will acquire the Healthcare Protective Products Division ( HPPD ) of Bracco's Bracco Diagnostics Inc. subsidiary for...
...$281.9 million in 2012 revenues, said HPPD revenues from 2010-12 averaged about $20 million annually. Bracco Diagnostics Inc....
BioCentury | Apr 15, 2013
Clinical News

Sonus regulatory update

...issued the injunction in April in response to an appeal by four companies - SNUS, Bracco Diagnostics Inc....
BioCentury | Jan 7, 2013
Company News

Advaxis management update

...O'Connor as SVP, chief legal and business development officer, formerly VP and general counsel at Bracco Diagnostics Inc. WIR...
BioCentury | Aug 6, 2012
Clinical News

MultiHance gadobenate dimeglumine regulatory update

...vascularity of the brain, spine and associated tissues. The product is also approved in Europe. Bracco Diagnostics Inc....
BioCentury | Feb 27, 2012
Clinical News

CardioGen-82 regulatory update

...radiation exposure during treatment. Bracco co-promotes CardioGen-82 with Lantheus Medical Imaging Inc. (North Billerica, Mass.). Bracco Diagnostics Inc....
BioCentury | Apr 7, 2011
Politics & Policy

FDA panel to discuss ultrasound contrast agents

...Co. (NYSE:GE); and an agent not approved in the U.S., sulfur hexafluoride microbubble injection from Bracco Diagnostics Inc....
BioCentury | Dec 14, 2009
Clinical News

Eovist gadoxetate disodium regulatory update

...from Bracco; as well as generics gadoteric acid and gadobutrol. Bayer AG (Xetra:BAY), Leverkusen, Germany Bracco Diagnostics Inc....
BioCentury | Dec 14, 2009
Clinical News

Eovist gadoxetate disodium regulatory update

...three products, but also discussed safety data for MultiHance gadobenate dimeglumine and ProHance gadoteridol from Bracco Diagnostics Inc....
...label to contraindicate its use in patients with renal impairment. Bayer AG (Xetra:BAY), Leverkusen, Germany Bracco Diagnostics Inc....
Items per page:
1 - 10 of 25